Semax
CognitiveNootropic research peptide (ACTH(4–10) analog).
Description
Semax is a synthetic peptide derived from a fragment of ACTH(4–10), supplied as a lyophilized powder for in-vitro research. It is studied in laboratory models of neuroprotection, BDNF expression, and cognitive signaling. Sold strictly for research use, not for human or veterinary use.
Storage & handling
Store lyophilized vials at -20 °C, protected from light and moisture. Keep sealed until use and avoid repeated freeze–thaw cycles. Handle per your laboratory's standard operating procedures.
Research applications
- Neuroprotection and neurotrophic (BDNF) research
- Cognitive-signaling pathway studies
- Analytical reference standard
Sold strictly for in-vitro laboratory research. Not for human or veterinary use, diagnosis, treatment, or consumption.
Research status
Where the published evidence stands for each active compound, with the primary source. Regulatory standing is listed for context only. Nothing sold here is approved for human use.
- SemaxApproved outside the U.S.
An ACTH(4–7) analog listed on Russia's register of vital and essential medicines since 2019. It holds no FDA or EMA authorization, and peer-reviewed Western trial data is limited.
PubMed 9173745 · Semax design and study
Researchers also viewed
“Purity matched the label exactly. Mass spec and HPLC both checked out. Reordering.”
Research associate, Raleigh, NC